Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.25 by 92 percent. This is a 96.97 percent decrease over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $4.142 billion which beat the analyst consensus estimate of $4.047 billion by 2.35 percent. This is a 1.38 percent decrease over sales of $4.200 billion the same period last year.